ALX Oncology

San Francisco, United States

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

Jun 2026

Post-IPO Debt

Top Investors

RA Capital ManagementJanus Henderson InvestorsVivo CapitalRedmile GroupForesite Capital

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are ALX Oncology's investors?

ALX Oncology's investors include RA Capital Management, Janus Henderson Investors, Vivo Capital, Redmile Group, Foresite Capital.

Where is ALX Oncology headquartered?

ALX Oncology is headquartered in San Francisco, United States.

What does ALX Oncology do?

ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

What stage is ALX Oncology at?

ALX Oncology is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 25, 2026.

MLA

"ALX Oncology — Funding & Investors." VCBacked, June 25, 2026, https://www.vcbacked.co/company/alx-oncology. Accessed June 30, 2026.

APA

VCBacked. (2026). ALX Oncology — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/alx-oncology

Wikipedia (cite web)

{{cite web |title=ALX Oncology — Funding & Investors |url=https://www.vcbacked.co/company/alx-oncology |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 25, 2026.